Gossamer Bio, Inc. (GOSS)
NASDAQ: GOSS · Real-Time Price · USD
0.1570
-0.0082 (-4.96%)
At close: Jun 26, 2026, 4:00 PM EDT
0.1625
+0.0055 (3.50%)
After-hours: Jun 26, 2026, 7:50 PM EDT
Gossamer Bio Market Cap
Gossamer Bio has a market cap or net worth of $76.75 million as of June 26, 2026. Its market cap has decreased by -73.83% in one year.
Market Cap
76.75M
Enterprise Value
180.47M
1-Year Change
-73.83%
Ranking
Category
Stock Price
$0.16
Market Cap Chart
Since February 8, 2019, Gossamer Bio's market cap has decreased from $995.26M to $76.75M, a decrease of -92.29%. That is a compound annual growth rate of -29.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 76.75M | -89.30% |
| Dec 31, 2025 | 717.51M | 250.03% |
| Dec 31, 2024 | 204.99M | -0.34% |
| Dec 29, 2023 | 205.69M | 0.56% |
| Dec 30, 2022 | 204.54M | -76.06% |
| Dec 31, 2021 | 854.34M | 21.87% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Feb 8, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| iBio, Inc. | 82.96M |
| Heron Therapeutics | 81.39M |
| OKYO Pharma | 81.34M |
| Entera Bio | 80.24M |
| MindWalk Holdings | 78.47M |
| Elicio Therapeutics | 76.29M |
| Gain Therapeutics | 74.64M |
| Annovis Bio | 73.17M |